EL102: A novel dual inhibitor which demonstrates additive prostate cancer inhibitory activity in combination with docetaxel in vitro and in mouse models

Sharon Glynn

EL102: A novel dual inhibitor which demonstrates additive prostate cancer inhibitory activity in combination with docetaxel in vitro and in mouse models

Sharon Glynn

Pathology

Research output: Chapter in Book or Conference Publication/Proceeding › Conference Publication › peer-review

Original language	English (Ireland)
Title of host publication	AACR Special Conference on Advances in Prostate Cancer Research
Publication status	Published - 1 Feb 2012

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being
SDG 7 Affordable and Clean Energy

Authors (Note for portal: view the doc link for the full list of authors)

Authors
Aidan Toner, Fiona McLaughlin, Jill McMahon, Francis J. Giles, Frank Sullivan, Laura Breen, Martin Clynes, Joe D. Lewis and Sharon A. Glynn

Cite this

@inproceedings{b9cbe64df6c24752bf076c7ea24c2fe2,

title = "EL102: A novel dual inhibitor which demonstrates additive prostate cancer inhibitory activity in combination with docetaxel in vitro and in mouse models",

author = "Sharon Glynn",

year = "2012",

month = feb,

day = "1",

language = "English (Ireland)",

booktitle = "AACR Special Conference on Advances in Prostate Cancer Research",

}